Suppr超能文献

青光眼患者中使用艾哈迈德植入物与贝尔维尔德植入物后并发症的比较:一年随访

Comparison of complications after Ahmed versus Baerveldt implant in glaucoma patients: one year follow-up.

作者信息

Koentjoro Sara Listyani, Artini Widya, Soebijantoro Iwan, Istiantoro Vira Wardhana, Rusmayani Emma, Sulastiwaty Rini, Djamal Zeiras Eka, Akbar Arini Safira Nurul, Yoserizal Muhammad

机构信息

Glaucoma Division, Jakarta Eye Center Hospital, West Jakarta, Special District Region of Jakarta 11520, Indonesia.

出版信息

Int J Ophthalmol. 2020 Dec 18;13(12):1908-1914. doi: 10.18240/ijo.2020.12.10. eCollection 2020.

Abstract

AIM

To compare surgical results of the Ahmed and Baerveldt implant procedures in glaucoma patients at 1y follow-up at Jakarta Eye Center (JEC) Eye Hospitals.

METHODS

This cohort retrospective study was conducted on glaucoma patients aged ≥18y who had undergone Ahmed and Baerveldt implant surgery. Intraocular pressure (IOP), visual acuity, glaucoma medication, success rate, early and late postoperative complications, and the number of resurgeries were analyzed.

RESULTS

A total of 351 eyes in the Ahmed group and 94 eyes in the Baerveldt group were included in this study. At 1y follow-up, the mean IOP was found to be significantly lower in the Baerveldt group (13±4.47 mm Hg) compared to the Ahmed group (15.02±5.73 mm Hg; =0.025). Glaucoma medication was required in both the Ahmed and Baerveldt groups (58.92% 71.67%). Comparable success rate was found in both groups. The Ahmed group revealed a complete and qualified success of 86.82%, and failure of 13.17%. Similarly, the Baerveldt group showed complete and qualified success in 87.75% and failure in 12.25% cases. In the Ahmed group, 11.97% early complications, 26.06% late complications and 9.97% resurgeries were observed. In comparison, in the Baerveldt group, 23.40% early complications, 30.95% late complications and 11.70% resurgeries were observed.

CONCLUSION

Both groups of glaucoma implants show significant IOP reduction, however, the Baerveldt implant group demonstrates greater IOP reduction with more failure rates and complications than the Ahmed implant group.

摘要

目的

比较雅加达眼科中心(JEC)眼科医院青光眼患者接受艾哈迈德(Ahmed)和贝尔维尔德(Baerveldt)植入手术1年随访后的手术效果。

方法

对年龄≥18岁且接受过艾哈迈德和贝尔维尔德植入手术的青光眼患者进行这项队列回顾性研究。分析眼压(IOP)、视力、青光眼药物治疗、成功率、术后早期和晚期并发症以及再次手术的次数。

结果

本研究纳入了艾哈迈德组的351只眼和贝尔维尔德组的94只眼。在1年随访时,发现贝尔维尔德组的平均眼压(13±4.47毫米汞柱)明显低于艾哈迈德组(15.02±5.73毫米汞柱;P = 0.025)。艾哈迈德组和贝尔维尔德组均需要进行青光眼药物治疗(分别为58.92%和71.67%)。两组的成功率相当。艾哈迈德组的完全成功和合格成功率为86.82%,失败率为13.17%。同样,贝尔维尔德组在87.75%的病例中显示完全成功和合格成功,12.25%的病例失败。在艾哈迈德组中,观察到11.97%的早期并发症、26.06%的晚期并发症和9.97%的再次手术。相比之下,在贝尔维尔德组中,观察到23.40%的早期并发症、30.95%的晚期并发症和11.70%的再次手术。

结论

两组青光眼植入物均显示眼压显著降低,然而,贝尔维尔德植入物组的眼压降低幅度更大,但失败率和并发症比艾哈迈德植入物组更多。

相似文献

5
The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.艾哈迈德对 Baerveldt 研究:五年治疗结果。
Ophthalmology. 2016 Oct;123(10):2093-102. doi: 10.1016/j.ophtha.2016.06.035. Epub 2016 Aug 17.
6
The Ahmed Versus Baerveldt study: one-year treatment outcomes.艾哈迈德对贝弗利特研究:一年治疗结果。
Ophthalmology. 2011 Nov;118(11):2180-9. doi: 10.1016/j.ophtha.2011.05.004. Epub 2011 Sep 1.
7
The Ahmed versus Baerveldt study: three-year treatment outcomes.艾哈迈德对贝弗利特研究:三年治疗结果。
Ophthalmology. 2013 Nov;120(11):2232-40. doi: 10.1016/j.ophtha.2013.04.018. Epub 2013 Jun 21.

本文引用的文献

1
Intracameral viscoelastic treatment for hypotony after glaucoma incisional surgery.前房内黏弹剂治疗青光眼切开术后低眼压
Taiwan J Ophthalmol. 2019 Dec 13;9(4):292-294. doi: 10.4103/tjo.tjo_31_18. eCollection 2019 Oct-Dec.
2
New developments in tube shunt surgery.管分流手术的新进展。
Curr Opin Ophthalmol. 2019 Mar;30(2):125-131. doi: 10.1097/ICU.0000000000000549.
4
Aqueous shunt implantation in glaucoma.青光眼的房水引流物植入术
Taiwan J Ophthalmol. 2017 Jul-Sep;7(3):130-137. doi: 10.4103/tjo.tjo_35_17.
8
The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.艾哈迈德对 Baerveldt 研究:五年治疗结果。
Ophthalmology. 2016 Oct;123(10):2093-102. doi: 10.1016/j.ophtha.2016.06.035. Epub 2016 Aug 17.
9
Tube Exposure Repair.导管暴露修复
J Curr Glaucoma Pract. 2012 Sep-Dec;6(3):139-42. doi: 10.5005/jp-journals-10008-1121. Epub 2012 Oct 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验